Skip to main content
Caplight Logo









iMerciv Inc.

iMerciv Inc.

Private
TorontoHealthcare & Life Scienceshttps://imerciv.com

Last Round

Grant

Nov 1, 2017

Total Funding Raised

$186,820

Company Overview

iMerciv Inc. operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Grant round in November 2017.

iMerciv Inc. is a health technology company that develops wearable assistive devices and navigation software for the visually impaired.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, NLP & Conversational AI

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

iMerciv Inc. Comparables

Compare iMerciv Inc. with similar companies based on industry and business-model similarity.

iMerciv Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
STRAP Technologies, Inc.
88%
Biped.ai
85%
Tec-Innovation GmbH
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

iMerciv Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 1, 2017
GrantMay 1, 2016
CrowdfundingNov 21, 2015
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

iMerciv Inc. Investors

Notable investors and investment history

iMerciv Inc. investors
InvestorRounds
Ontario Centre of InnovationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2017

    $100K grant received from TELUS Corporation.

  • May 1, 2016

    $20K grant received from Ontario Centre of Innovation.

Book a demo to see all signals

For institutional investors. Book with your work email.

iMerciv Inc. Filings

Explore SEC and related filing metadata, where available.

iMerciv Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about iMerciv Inc.'s valuation, stock price, and market status.

Is iMerciv Inc. a public or private company?

iMerciv Inc. is a private company.

What is the current stock price of iMerciv Inc.?

iMerciv Inc. is a private company, so its shares have no public market price. Caplight tracks iMerciv Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is iMerciv Inc. worth (valuation)?

Valuation information for iMerciv Inc. is not publicly available.

Can I buy iMerciv Inc. stock?

iMerciv Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was iMerciv Inc.'s last funding round?

iMerciv Inc.'s most recent funding round was Grant on November 1, 2017.

Who are the main investors in iMerciv Inc.?

Key investors in iMerciv Inc. include Ontario Centre of Innovation.

Will iMerciv Inc. IPO soon?

No public IPO plans have been announced for iMerciv Inc..

How can I track iMerciv Inc. secondary market activity?

Caplight tracks bids, offers, and trades in iMerciv Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersToronto
Employee Range1
Year Founded2014
Last FundingNov 1, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?